378
Views
3
CrossRef citations to date
0
Altmetric
REVIEW

Illness Perceptions, Cognitions, and Beliefs on COPD Patients’ Adherence to Treatment – A Systematic Review

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 1845-1866 | Received 05 Apr 2023, Accepted 07 Jun 2023, Published online: 28 Jul 2023

References

  • Adeloye D, Song P, Zhu Y, Campbell H, Sheikh A, Rudan I. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022;10(5):447–458. doi:10.1016/S2213-2600(21)00511-7
  • Thys van der Molen C, van der Molen T, Maguire T, Goyal P, Altman P. Optimizing identification and management of COPD patients–reviewing the role of the community pharmacist. Br J Clin Pharmacol. 2016;83(1):192–201. doi:10.1111/bcp.13087
  • Cazzola M, Page C, Rogliani P, Calzetta L, Matera MG. Multifaceted beneficial effects of erdosteine: more than a mucolytic agent. Drugs. 2020;80(17):1799–1809. doi:10.1007/S40265-020-01412-X
  • Khor YH, Renzoni EA, Visca D, McDonald CF, Goh NSL. Oxygen therapy in COPD and interstitial lung disease: navigating the knowns and unknowns. ERJ Open Res. 2019;5(3):1–8. doi:10.1183/23120541.00118-2019
  • Ambrosino N, Vagheggini G. Non-invasive ventilation in exacerbations of COPD. Int J Chron Obstruct Pulmon Dis. 2007;2(4):471–476.
  • Wouters EFM, Posthuma R, Koopman M, et al. An update on pulmonary rehabilitation techniques for patients with chronic obstructive pulmonary disease. Expert Rev Respir Med. 2020;14:149–161. doi:10.1080/17476348.2020.1700796
  • Marchetti N, Criner GJ. Surgical approaches to treating emphysema: lung volume reduction surgery, bullectomy, and lung transplantation. Semin Respir Crit Care Med. 2015;36(4):592–608. doi:10.1055/S-0035-1556064
  • Horwitz R. Adherence to treatment and health outcomes. Arch Intern Med. 1993;153(16):1863–1868. doi:10.1001/archinte.1993.00410160017001
  • Bhattarai B, Walpola R, Mey A, Anoopkumar-Dukie S, Khan S. Barriers and Strategies for Improving Medication Adherence Among People Living With COPD: a Systematic Review. Respir Care. 2020;65:1738–1750. doi:10.4187/respcare.07355
  • Humenberger M, Horner A, Labek A, et al. Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD) 11 medical and health sciences 1102 cardiorespiratory medicine and haematology. BMC Pulm Med. 2018;18(1). doi:10.1186/S12890-018-0724-3
  • Bourbeau J, Thorax SB. Patient adherence in COPD. Thorax. 2008;63:831–838. doi:10.1136/thx.2007.086041
  • Rogliani P, Ora J, Puxeddu E, Matera MG, Cazzola M. Adherence to COPD treatment: myth and reality. Respir Med. 2017;129:117–123. doi:10.1016/J.RMED.2017.06.007
  • López-Pintor E, Grau J, González I, Bernal-Soriano MC, Quesada JA, Lumbreras B. Impact of patients’ perception of COPD and treatment on adherence and health-related quality of life in real-world: study in 53 community pharmacies. Respir Med. 2021;176:106280. doi:10.1016/j.rmed.2020.106280
  • Vetrano DL, Bianchini E, Onder G, et al. Poor adherence to chronic obstructive pulmonary disease medications in primary care: role of age, disease burden and polypharmacy. Geriatr Gerontol Int. 2017;17(12):2500–2506. doi:10.1111/ggi.13115
  • Khdour MR, Hawwa AF, Kidney JC, Smyth BM, McElnay JC. Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD). Eur J Clin Pharmacol. 2012;68(10):1365–1373. doi:10.1007/S00228-012-1279-5/METRICS
  • George M, Bender B. New insights to improve treatment adherence in asthma and COPD. Patient Prefer Adherence. 2019;13:1325. doi:10.2147/PPA.S209532
  • Miravitlles M, Ribera A. Understanding the impact of symptoms on the burden of COPD. Respir Res. 2017;18(1). doi:10.1186/S12931-017-0548-3
  • Hynninen KMJ, Breitve MH, Wiborg AB, Pallesen S, Nordhus IH. Psychological characteristics of patients with chronic obstructive pulmonary disease: a review. J Psychosom Res. 2005;59(6):429–443. doi:10.1016/j.jpsychores.2005.04.007
  • Volpato E, Toniolo S, Pagnini F, Banfi P. The relationship between anxiety, depression and treatment adherence in chronic obstructive pulmonary disease: a systematic review. Int J Chron Obstruct Pulmon Dis. 2021;Volume 16:2001–2021. doi:10.2147/COPD.S313841
  • Kohler CL, Fish L, Greene PG. The relationship of perceived self-efficacy to quality of life in chronic obstructive pulmonary disease. Heal Psychol. 2002;21(6):610–614. doi:10.1037/0278-6133.21.6.610
  • Milenkovic B, Latas M, Cvejic J, Jankovic J. Alexithymia in COPD patients. Eur Respir J. 2015;46(suppl 59):OA2909. doi:10.1183/13993003.CONGRESS-2015.OA2909
  • Scharloo M, Kaptein A. Illness perceptions and quality of life in patients with chronic obstructive pulmonary disease. J Asthma. 2008;45(8):625–629. doi:10.1080/02770900802127048
  • Leventhal H, Nerenz DR, Steele DJ. Illness representations and coping with health threats. Handb Psychol Heal Vol IV Soc Psychol Asp Heal. 2020;219–252. doi:10.4324/9781003044307-9/ILLNESS-REPRESENTATIONS-COPING-HEALTH-THREATS-HOWARD-LEVENTHAL-DAVID-NERENZ-DAVID-STEELE
  • Cameron LD, Leventhal H. The self-regulation of health and illness behaviour. Self Regulation Heal Illn Behav. 2012;1–346. doi:10.4324/9780203553220
  • von Leupoldt A, Dahme B. Psychological aspects in the perception of dyspnea in obstructive pulmonary diseases. Respir Med. 2007;101(3):411–422. doi:10.1016/j.rmed.2006.06.011
  • Brewer N, Chapman G, Brownlee S, Leventhal EA. Cholesterol control, medication adherence and illness cognition. Br J Health Psychol. 2002;7(4):433–447. doi:10.1348/135910702320645408
  • Årestedt L, Benzein E, Persson C. Families living with chronic illness: beliefs about illness, family, and health care. J Fam Nurs. 2015;21(2):206–231. doi:10.1177/1074840715576794
  • Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi:10.1371/JOURNAL.PMED.1000097
  • Fischer MJ, Scharloo M, Abbink JJ, et al. Drop-out and attendance in pulmonary rehabilitation: the role of clinical and psychosocial variables. Respir Med. 2009;103(10):1564–1571. doi:10.1016/J.RMED.2008.11.020
  • Heerema-Poelman A, Stuive I, Wempe JB. Adherence to a maintenance exercise program 1 year after pulmonary rehabilitation: what are the predictors of dropout? J Cardiopulm Rehabil Prev. 2013;33(6):419–426. doi:10.1097/HCR.0b013e3182a5274a
  • Ter HKK, Brusse-Keizer M, van der Valk P, Movig K, van der Palen J, Bode C. Patients with underuse or overuse of inhaled corticosteroids have different perceptions and beliefs regarding COPD and inhaled medication. Patient Prefer Adherence. 2018;12:1777. doi:10.2147/PPA.S167002
  • Baiardini I, Contoli M, Corsico AG, et al. Exploring the relationship between disease awareness and outcomes in patients with chronic obstructive pulmonary disease. Respiration. 2021;100(4):291–297. doi:10.1159/000513953
  • Contoli M, Rogliani P. Satisfaction with chronic obstructive pulmonary disease treatment: results from a multicenter, observational study. Ther Adv Respir Dis. 2019;2019:13. doi:10.1177/1753466619888128
  • Pierobon A, Bottelli ES, Ranzini L, et al. COPD patients’ self-reported adherence, psychosocial factors and mild cognitive impairment in pulmonary rehabilitation. Int J COPD. 2017;12:2059–2067. doi:10.2147/COPD.S133586
  • Dermatologii Alergologii P, Olszanecka-Glinianowicz M, Almgren-Rachtan A. Original paper<br>The adherence and illness perception of patients diagnosed with asthma or chronic obstructive pulmonary disease treated with polytherapy using new generation cyclohaler. Adv Dermatology Allergol. 2014;31(4):235–246. doi:10.5114/PDIA.2014.45070
  • Hom˛ Etowska H, Swi N, Klekowski J, Chabowski M, Jankowska-Polá Nska B. Treatment adherence in patients with obstructive pulmonary diseases. Int J Environ Res Public Health. 2022;19. doi:10.3390/ijerph191811573
  • Agarwal P, Lin J, Muellers K, O’Conor R. A structural equation model of relationships of health literacy, illness and medication beliefs with medication adherence among patients with chronic obstructive. Patient Educ Couns. 2021;104(6):1445–1450. doi:10.1016/j.pec.2020.11.024
  • Krauskopf K, Federman AD, Kale MS, et al. Chronic obstructive pulmonary disease illness and medication beliefs are associated with medication adherence. COPD. 2014;12(2):151–164. doi:10.3109/15412555.2014.922067
  • Brandstetter S, Finger T, Fischer W, et al. Differences in medication adherence are associated with beliefs about medicines in asthma and COPD. Clin Transl Allergy. 2017;7(1):1–7. doi:10.1186/S13601-017-0175-6/TABLES/3
  • Duarte-de-Araújo A, Teixeira P, Hespanhol V, Correia-de-Sousa J. COPD: understanding patients’ adherence to inhaled medications. Int J Chron Obstruct Pulmon Dis. 2018;Volume 13:2767–2773. doi:10.2147/COPD.S160982
  • Chan AHY, Horne R, Hankins M, Chisari C. The medication adherence report scale: a measurement tool for eliciting patients’ reports of nonadherence. Br J Clin Pharmacol. 2020;86(7):1281–1288. doi:10.1111/BCP.14193
  • Morisky D, Green L. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 2022;2022:1.
  • Plaza V, Fernández-Rodríguez C, Melero C, et al. Validation of the “Test of the Adherence to Inhalers” (TAI) for asthma and COPD patients. J Aerosol Med Pulm Drug Deliv. 2016;29(2):142–152. doi:10.1089/JAMP.2015.1212/ASSET/IMAGES/LARGE/FIGURE3.JPEG
  • Weinman J, Petrie K, Moss-morris R, Horne R. The illness perception questionnaire: a new method for assessing the cognitive representation of illness. Psychol Health. 1996;11(3):431–445. doi:10.1080/08870449608400270
  • Broadbent E, Petrie K, Main J, Weinman J. The brief illness perception questionnaire. J Psychosom Res. 2006;60(6):631–637. doi:10.1016/j.jpsychores.2005.10.020
  • Moss-Morris R, Weinman J, Petrie K, Horne R, Cameron L, Buick D. The Revised Illness Perception Questionnaire (IPQ-R). Psychol Heal. 2002;17(1):1–16. doi:10.1080/08870440290001494
  • Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 2007;14(1):1–24. doi:10.1080/08870449908407311
  • Rosenstock IM. The health belief model and preventive health behavior. Heal Educ Behav. 1977;2(4):354–386. doi:10.1177/109019817400200405
  • Sabaté E, Sabaté E Adherence to long-term therapies: evidence for action; 2003. Available from: https://books.google.com/books?hl=it&lr=&id=kcYUTH8rPiwC&oi=fnd&pg=PR5&dq=Sabate+E.+Adherence+to+long-term+therapies:+evidence+for+action.+Geneva:+World+Health+Organization%3B+2003&ots=tC0Qer5fq_&sig=z_oP25oWkxsKzUnNsPJc-OEEB8g. Accessed April 10, 2021.
  • Hughes CM. Medication non-adherence in the elderly: how big is the problem? Drugs Aging. 2004;21(12):793–811. doi:10.2165/00002512-200421120-00004
  • Mirza S, Clay RD, Koslow MA, Scanlon PD. COPD guidelines: a review of the 2018 GOLD report. Mayo Clin Proc. 2018;93(10):1488–1502. doi:10.1016/J.MAYOCP.2018.05.026
  • Gerretsen P, Mallar Chakravarty M, Mamo D, et al. Illness awareness in cancer patients: a conceptual framework and a preliminary classification hypothesis. Psycho Oncol. 2013;34(5):1035–1043. doi:10.1002/hbm.21490